Overall, our data suggest that activin-A-mediated lung tumor regression is associated with increased numbers of tumor-infiltrating CD4+ T cells with effector phenotype at the expense of CD4+ T cells with suppressive properties. The gene discussed is CD4; the disease is neoplasm.